10:30 AM-12:15 PM
Sponsored by the ASIP Cardiac and Vascular Pathobiology Scientific Interest Group and the ASIP Neoplasia, Tumor Microenvironment, and Metastasis Scientific Interest Group
Session Room: TBD
Traci Parry, PhD
University of North Carolina, Greensboro
Maria Zambrano
Tufts University
This session delves into the molecular and cellular mechanisms underlying cardiovascular toxicity induced by anti cancer therapies, focusing on how targeted agents and chemotherapeutics disrupt cardiomyocyte signaling, mitochondrial integrity, and stress response pathways. Speakers will outline emerging frameworks that explain differential susceptibility to cardiac injury, including maladaptive kinase activation, oxidative stress, and metabolic dysfunction. This session also examines how lifestyle based interventions modulate these pathways, highlighting evidence that exercise holds value as an adjuvant therapy for attenuating treatment induced toxicity.
Co-Chair – Welcome and Introductions
10:30-10:55 AM
MEK Inhibitor Cardiotoxicity: From MEKanism to Clinical Prediction
Brian Jensen, MD
University of North Carolina
10:55-11:20 AM
Exercise as a Strategy to Mitigate Chemotherapy-Related Cardiotoxicity
Ashley Smuder, PhD
University of Florida
11:20-11:45 AM
Lifestyle Interventions for Toxicity Mitigation
Keri Schadler, PhD
The University of Texas MD Anderson Cancer Center
11:45 AM-12:00 PM
Abstract 1
12:00-12:15 PM
Abstract 2